Avadel Cns Pharmaceuticals, LLC

MO · United States · Reporting entity ID 100000786824

Total reported 2019–2025

$6.24M

#635 of 2,960 reporting companies — 0% of all reported industry payments

$3.55M in general payments across 22,971 records, plus $2.69M in research funding across 52 records.

How it breaks down

General payments $3,554,976

Research funding $2,689,983

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.